Drug Class - Antiplatelets

Front 1

Name 3 groups of antiplatelets?

Back 1

glycoprotein IIb/IIIa
inhibitors
platelet adhesion inhibitors
platelet aggregation
inhibitors

Front 2

Name two glycoprotein IIb/IIIa inhibitors?

Back 2

eptifibatide Integrilin
tirofiban Aggrastat

Front 3

Name one platelet adhesion
inhibitor?

Back 3

dipyridamole {Apo-Dipyridamole}, Dipridacot, {Novodipiradol}, Persantine, Persantine IV

Front 4

Name 3 platelet aggregation inhibitors?

Back 4

cilostazol Pletal

clopidogrel Plavix

ticlopidine Ticlid

Front 5

Antiplatelet agents are used to treat and prevent _____ events such as stroke and MI.

Back 5

thromboembolic

Front 6

_______ is commonly used after cardiac surgery.

Back 6

Dipyridamole

Front 7

Which 4 agents are used to inhibit platelet aggregation, prolong bleeding time, and prevent MI or stroke?

Back 7

aspirin
clopidogrel
dipyridamole
ticlopidine

Front 8

Which two agents are used in the management of various acute coronary syndromes?

Back 8

eptifibatide
tirofiban

These agents have been used concurrently/sequentially with anticoagulants and thrombolytics.

Front 9

Antiplatelets are contraindicated in these 4?

Back 9

hypersensitivity
ulcer disease
active bleeding
recent surgery

Front 10

Use antiplatelets cautiously in patients at risk for? (4)

Back 10

bleeding from trauma
bleeding from surgery
GI bleed
ulcer disease

Front 11

Safety of platelets has not been established in pregnancy, lactation, or children.

Back 11

okay

Front 12

Concurrent use with which 4 agents may increase the risk of bleeding?

Back 12

NSAIDs
heparin
thrombolytics
warfarin

Front 13

Assess patient for evidence of additional or increased ____. Symptoms will depend on area of involvement.

Back 13

thrombosis

Front 14

Assess patient taking antiplatelet agents for symptoms of (3) periodically throughout therapy.

Back 14

stroke
peripheral vascular disease
MI

Front 15

Monitor _____ time throughout antiplatelet therapy. Prolonged bleeding time, which is time- and dose-dependent, is expected.

Back 15

bleeding

Front 16

Potential Nursing Diagnoses?
(3)

Back 16

Tissue perfusion, ineffective
Injury, risk for
Knowledge, deficient, related
to disease processes and
medication regimen

Front 17

Use an infusion pump with _____ infusions to ensure accurate dosage.

Back 17

continuous

Front 18

Instruct patient to notify hcp immediately if any _____ is noted.

Back 18

bleeding

Front 19

Effectiveness of therapy can be demonstrated by? (3)

Back 19

prevention of stroke, MI, and vascular death in patients at risk